Skip to main content
OpenTrials

Clinical trial condition

ER/Progressive Response (PR) + Refractory to Prior Hormonal Treatment

Explore clinical trials studying ER/Progressive Response (PR) + Refractory to Prior Hormonal Treatment. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

ER/Progressive Response (PR) + Refractory to Prior Hormonal Treatment trial results

Completed

An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast Cancer

NCT01677455

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • Synta Pharmaceuticals Investigative Site Birmingham, Alabama, United States
  • Synta Pharmaceuticals Investigative Site Altanta, Georgia, United States
  • Synta Pharmaceuticals Investigative Site Boston, Massachusetts, United States
  • Synta Pharmaceuticals Investigative Site New York, United States
View all 25 locations
View Trial Details

Related conditions